Paper8680709
Blockade by sigma site ligands of high voltage-activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones.
Church J and 1 other. Br J Pharmacol, 1995. Cited by 51 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Blockade by sigma site ligands of high voltage-activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones. Papers, record 8680709. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8680709
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Blockade by sigma site ligands of high voltage-activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium Channels | Major topic |
| Pyramidal Cells | Major topic |
| Receptors, sigma | Major topic |
| Animals | |
| Cells, Cultured | |
| Evaluation Studies as Topic | |
| Ion Channel Gating | |
| Ligands | |
| Mice | |
| Rats | |
| Rats, Wistar | |
| Structure-Activity Relationship |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3,026,832 | Calcium and epileptogenesis. | Exp Brain Res | 1986 | https://conductscience.org/library/papers/3026832 | PubMed |
| 2 | 8,680,708 | Blockade by sigma site ligands of N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurones. | Br J Pharmacol | 1995 | https://conductscience.org/library/papers/8680708 | PubMed |
| 3 | 2,897,876 | The sigma receptor: a novel site implicated in psychosis and antipsychotic drug efficacy. | Clin Neuropharmacol | 1988 | https://conductscience.org/library/papers/2897876 | PubMed |
| 4 | 2,849,051 | Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses. | Mol Pharmacol | 1988 | https://conductscience.org/library/papers/2849051 | PubMed |
| 5 | 2,536,430 | Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands. | J Pharmacol Exp Ther | 1989 | https://conductscience.org/library/papers/2536430 | PubMed |
| 6 | 2,536,463 | Effects of dextromethorphan site ligands and allosteric modifiers on the binding of (+)-[3H]3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine. | Mol Pharmacol | 1989 | https://conductscience.org/library/papers/2536463 | PubMed |
| 7 | 2,469,160 | Multiple types of neuronal calcium channels and their selective modulation. | Trends Neurosci | 1988 | https://conductscience.org/library/papers/2469160 | PubMed |
| 8 | 2,569,504 | Regulation of sigma-receptors: high- and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-Di(2-tolyl)guanidine. | J Neurochem | 1989 | https://conductscience.org/library/papers/2569504 | PubMed |
| 9 | 2,548,673 | Three types of voltage-dependent calcium current in cultured rat hippocampal neurons. | Brain Res | 1989 | https://conductscience.org/library/papers/2548673 | PubMed |
| 10 | 2,477,524 | High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents. | J Pharmacol Exp Ther | 1989 | https://conductscience.org/library/papers/2477524 | PubMed |
| 11 | 2,694,543 | Dextromethorphan and neuromodulation: old drug coughs up new activities. | Trends Pharmacol Sci | 1989 | https://conductscience.org/library/papers/2694543 | PubMed |
| 12 | 2,171,718 | The pharmacotherapy of focal cortical ischaemia in the mouse. | Brain Res | 1990 | https://conductscience.org/library/papers/2171718 | PubMed |
| 13 | 2,172,538 | Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma receptor ligands. Identification of a new class of highly potent and selective sigma receptor probes. | J Med Chem | 1990 | https://conductscience.org/library/papers/2172538 | PubMed |
| 14 | 2,282,497 | Effects of non-opioid antitussives on epileptiform activity and NMDA responses in hippocampal and olfactory cortex slices. | Brain Res | 1990 | https://conductscience.org/library/papers/2282497 | PubMed |
| 15 | 1,847,494 | [3H]opipramol labels a novel binding site and sigma receptors in rat brain membranes. | Mol Pharmacol | 1991 | https://conductscience.org/library/papers/1847494 | PubMed |
| 16 | 1,847,495 | Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands. | Mol Pharmacol | 1991 | https://conductscience.org/library/papers/1847495 | PubMed |
| 17 | 1,963,213 | Sigma-ligands and non-competitive NMDA antagonists inhibit glutamate release during cerebral ischemia. | Neurosci Lett | 1990 | https://conductscience.org/library/papers/1963213 | PubMed |
| 18 | 1,963,477 | Opipramol, a potent sigma ligand, is an anti-ischemic agent: neurochemical evidence for an interaction with the N-methyl-D-aspartate receptor complex in vivo by cerebellar cGMP measurements. | Neuropharmacology | 1990 | https://conductscience.org/library/papers/1963477 | PubMed |
| 19 | 1,964,225 | Sigma receptors: biology and function. | Pharmacol Rev | 1990 | https://conductscience.org/library/papers/1964225 | PubMed |
| 20 | 1,645,678 | Inhibition of K(+)-evoked [3H]D-aspartate release and neuronal calcium influx by verapamil, diltiazem and dextromethorphan: evidence for non-L/non-N voltage-sensitive calcium channels. | Eur J Pharmacol | 1991 | https://conductscience.org/library/papers/1645678 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,807,554 | Treatment of cholinergic-induced status epilepticus with polytherapy targeting GABA and glutamate receptors. | Epilepsia Open | 2023 | https://conductscience.org/library/papers/36807554 | PubMed |
| 34,736,882 | Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders. | Neurosci Biobehav Rev | 2022 | https://conductscience.org/library/papers/34736882 | PubMed |
| 34,658,788 | Sigma-1 Receptor: A Potential Therapeutic Target for Traumatic Brain Injury. | Front Cell Neurosci | 2021 | https://conductscience.org/library/papers/34658788 | PubMed |
| 32,668,330 | PRE-084 as a tool to uncover potential therapeutic applications for selective sigma-1 receptor activation. | Int J Biochem Cell Biol | 2020 | https://conductscience.org/library/papers/32668330 | PubMed |
| 31,780,884 | The Sigma-1 Receptor: When Adaptive Regulation of Cell Electrical Activity Contributes to Stimulant Addiction and Cancer. | Front Neurosci | 2019 | https://conductscience.org/library/papers/31780884 | PubMed |
| 31,551,669 | Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases. | Front Neurosci | 2019 | https://conductscience.org/library/papers/31551669 | PubMed |
| 29,713,995 | Full Protection Against Soman-Induced Seizures and Brain Damage by LY293558 and Caramiphen Combination Treatment in Adult Rats. | Neurotox Res | 2018 | https://conductscience.org/library/papers/29713995 | PubMed |
| 29,467,308 | Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population. | J Pharmacol Exp Ther | 2018 | https://conductscience.org/library/papers/29467308 | PubMed |
| 28,990,373 | Sigma-1 receptor agonist increases axon outgrowth of hippocampal neurons via voltage-gated calcium ions channels. | CNS Neurosci Ther | 2017 | https://conductscience.org/library/papers/28990373 | PubMed |
| 26,056,947 | Sigma receptors [σRs]: biology in normal and diseased states. | J Recept Signal Transduct Res | 2016 | https://conductscience.org/library/papers/26056947 | PubMed |
| 25,122,884 | Synaptic GluN2A and GluN2B containing NMDA receptors within the superficial dorsal horn activated following primary afferent stimulation. | J Neurosci | 2014 | https://conductscience.org/library/papers/25122884 | PubMed |
| 24,891,452 | Sigma-1 receptor antagonism restores injury-induced decrease of voltage-gated Ca2+ current in sensory neurons. | J Pharmacol Exp Ther | 2014 | https://conductscience.org/library/papers/24891452 | PubMed |
| 22,433,979 | Sigma-1 receptor alters the kinetics of Kv1.3 voltage gated potassium channels but not the sensitivity to receptor ligands. | Brain Res | 2012 | https://conductscience.org/library/papers/22433979 | PubMed |
| 21,486,285 | Neuroprotective efficacy of caramiphen against soman and mechanisms of its action. | Br J Pharmacol | 2011 | https://conductscience.org/library/papers/21486285 | PubMed |
| 19,279,232 | Voltage-gated sodium channel modulation by sigma-receptors in cardiac myocytes and heterologous systems. | Am J Physiol Cell Physiol | 2009 | https://conductscience.org/library/papers/19279232 | PubMed |
| 15,197,533 | Sigma receptors: biology and therapeutic potential. | Psychopharmacology (Berl) | 2004 | https://conductscience.org/library/papers/15197533 | PubMed |
| 14,978,511 | Review of the pharmacological and clinical profile of rimcazole. | CNS Drug Rev | 2004 | https://conductscience.org/library/papers/14978511 | PubMed |
| 9,084,059 | Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors. | Psychopharmacology (Berl) | 1997 | https://conductscience.org/library/papers/9084059 | PubMed |
| 8,680,708 | Blockade by sigma site ligands of N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurones. | Br J Pharmacol | 1995 | https://conductscience.org/library/papers/8680708 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8680709
GET https://conductscience.org/api/papers/v1/8680709/references?page=2